Incurable Platinum Refractory Germ Cell Tumors
1 clinical trials · Condition
◉ Watch Incurable Platinum Refractory Germ Cell Tumors
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors (NCT03760081) | Astellas Pharma Global Development, Inc. | 2019-03-19 |
Track Incurable Platinum Refractory Germ Cell Tumors automatically
Every clearance here is in the API, with alerts when new ones post.